Virus-Specific Differences in Rates of Disease during the 2010 Dengue Epidemic in Puerto Rico

PLoS Neglected Tropical Diseases

Volumn 7, Issue 4, 2013, Pages

  Sharp, Tyler M ^a,b   Hunsperger, Elizabeth ^b   Santiago, Gilberto A ^b   Muñoz Jordan, Jorge L ^b   Santiago, Luis M ^b   Rivera, Aidsa ^b   Rodríguez Acosta, Rosa L ^a,b   Gonzalez Feliciano, Lorenzo ^c   Margolis, Harold S ^b   Tomashek, Kay M ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (Puerto Rico)

^c Puerto Rico Department of Health   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; GENE SEQUENCE; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; INFECTION RATE; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRESCHOOL CHILD; PRIMARY INFECTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SECONDARY INFECTION; UNINDEXED SEQUENCE;

EID: 84876849462     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002159     Document Type: Article

References (58)

1. Gubler DJ, (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10: 100-103.
2. World Health Organization (2009) Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. First edition. Geneva: WHO. http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf.
3. World Health Organization (1997) Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. Second edition. Geneva: WHO. http://www.who.int/csr/resources/publications/dengue/Denguepublication/en/.
4. Effler PV, Pang L, Kitsutani P, Vorndam V, Nakata M, et al. (2005) Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis 11: 742-749.
5. Rodhain R, Rosen L., editor (1997) Dengue and dengue hemorrhagic fever. New York: CAB International. 45-60 p.
6. Murphy BR, Whitehead SS, (2011) Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 29: 587-619.
7. Halstead SB, Nimmannitya S, Cohen SN, (1970) Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 42: 311-328.
8. Whitehead SS, Blaney JE, Durbin AP, Murphy BR, (2007) Prospects for a dengue virus vaccine. Nat Rev Microbiol 5: 518-528.
9. United States Census Bureau (2010) American Fact Finder. http://factfinder2.census.gov/faces/nav/jsf/pages/index.xhtml.
10. King W, (1917) The epidemic of dengue in Puerto Rico: 1915. New Orleans Medical Surgergy 69: 573-579.
11. Neff JM, Morris L, Gonzalez-Alcover R, Coleman PH, Lyss SB, et al. (1967) Dengue fever in a Puerto Rican community. Am J Epidemiol 86: 162-184.
12. Likosky WH, Calisher CH, Michelson AL, Correa-Coronas R, Henderson BE, et al. (1973) An epidermiologic study of dengue type 2 in Puerto Rico, 1969. Am J Epidemiol 97: 264-275.
13. Lopez-Correa RH, Cline BL, Ramirez-Ronda C, Bermudez R, Sather GE, et al. (1978) Dengue fever with hemorrhagic manifestations: a report of three cases from Puerto Rico. Am J Trop Med Hyg 27: 1216-1224.
14. Morens DM, Rigau-Perez JG, Lopez-Correa RH, Moore CG, Ruiz-Tiben EE, et al. (1986) Dengue in Puerto Rico, 1977: public health response to characterize and control an epidemic of multiple serotypes. Am J Trop Med Hyg 35: 197-211.
15. Gubler DJ, (2006) Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp 277: 3-16; discussion 16-22, 71-13, 251-253.
16. Gubler DJ, (1987) Dengue and dengue hemorrhagic fever in the Americas. P R Health Sci J 6: 107-111.
17. Dietz V, Gubler DJ, Ortiz S, Kuno G, Casta-Velez A, et al. (1996) The 1986 dengue and dengue hemorrhagic fever epidemic in Puerto Rico: epidemiologic and clinical observations. P R Health Sci J 15: 201-210.
18. Rigau-Perez JG, Vorndam AV, Clark GG, (2001) The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. Am J Trop Med Hyg 64: 67-74.
19. Rigau-Perez JG, Ayala-Lopez A, Garcia-Rivera EJ, Hudson SM, Vorndam V, et al. (2002) The reappearance of dengue-3 and a subsequent dengue-4 and dengue-1 epidemic in Puerto Rico in 1998. Am J Trop Med Hyg 67: 355-362.
20. Tomashek KM, Rivera A, Munoz-Jordan JL, Hunsperger E, Santiago L, et al. (2009) Description of a large island-wide outbreak of dengue in Puerto Rico, 2007. Am J Trop Med Hyg 81: 467-474.
21. Ramos MM, Arguello DF, Luxemburger C, Quinones L, Munoz JL, et al. (2008) Epidemiological and clinical observations on patients with dengue in Puerto Rico: results from the first year of enhanced surveillance-June 2005-May 2006. Am J Trop Med Hyg 79: 123-127.
22. Tomashek KM, Gregory CJ, Rivera Sanchez A, Bartek MA, Garcia Rivera EJ, et al. (2012) Dengue deaths in Puerto Rico: lessons learned from the 2007 epidemic. PLoS neglected tropical diseases 6: e1614.
23. Prince HE, Matud JL, Lieberman JM, (2011) Dengue virus immunoglobulin M detection in a reference laboratory setting during the 2010 dengue virus outbreak on Caribbean islands. Clin Vaccine Immunol 18: 1104-1107.
24. Johnson BW, Russell BJ, Lanciotti RS, (2005) Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J Clin Microbiol 43: 4977-4983.
25. Burke DS, Nisalak A, Ussery MA, (1982) Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol 16: 1034-1042.
26. Martin DA, Biggerstaff BJ, Allen B, Johnson AJ, Lanciotti RS, et al. (2002) Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 9: 544-549.
27. Guarner J, Bhatnagar J, Shieh WJ, Nolte KB, Klein D, et al. (2007) Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis. Hum Pathol 38: 1412-1419.
28. Bhatnagar J, Blau DM, Shieh WJ, Paddock CD, Drew C, et al. (2012) Molecular detection and typing of dengue viruses from archived tissues of fatal cases by rt-PCR and sequencing: diagnostic and epidemiologic implications. The American journal of tropical medicine and hygiene 86: 335-340.
29. Johnson AJ, Martin DA, Karabatsos N, Roehrig JT, (2000) Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol 38: 1827-1831.
30. Miagostovich MP, Nogueira RM, dos Santos FB, Schatzmayr HG, Araujo ES, et al. (1999) Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis. J Clin Virol 14: 183-189.
31. Kuno G, Gubler DJ, Velez M, Oliver A, (1985) Comparative sensitivity of three mosquito cell lines for isolation of dengue viruses. Bull World Health Organ 63: 279-286.
32. Twiddy SS, Farrar JJ, Vinh Chau N, Wills B, Gould EA, et al. (2002) Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. Virology 298: 63-72.
33. Rico-Hesse R, (2003) Microevolution and virulence of dengue viruses. Adv Virus Res 59: 315-341.
34. Goncalvez AP, Escalante AA, Pujol FH, Ludert JE, Tovar D, et al. (2002) Diversity and evolution of the envelope gene of dengue virus type 1. Virology 303: 110-119.
35. Bennett SN, Holmes EC, Chirivella M, Rodriguez DM, Beltran M, et al. (2006) Molecular evolution of dengue 2 virus in Puerto Rico: positive selection in the viral envelope accompanies clade reintroduction. J Gen Virol 87: 885-893.
36. McElroy KL, Santiago GA, Lennon NJ, Birren BW, Henn MR, et al. (2011) Endurance, refuge, and reemergence of dengue virus type 2, Puerto Rico, 1986-2007. Emerg Infect Dis 17: 64-71.
37. Lanciotti RS, Gubler DJ, Trent DW, (1997) Molecular evolution and phylogeny of dengue-4 viruses. J Gen Virol 78 (Pt 9) (): 2279-2284.
38. Johansson MA, Cummings DA, Glass GE, (2009) Multiyear climate variability and dengue-El Nino southern oscillation, weather, and dengue incidence in Puerto Rico, Mexico, and Thailand: a longitudinal data analysis. PLoS Med 6: e1000168.
39. Johansson MA, Dominici F, Glass GE, (2009) Local and global effects of climate on dengue transmission in Puerto Rico. PLoS neglected tropical diseases 3: e382.
40. Gubler DJ, Trent DW, (1993) Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis 2: 383-393.
41. Anez G, Heisey DA, Espina LM, Stramer SL, Rios M, (2012) Phylogenetic analysis of dengue virus types 1 and 4 circulating in Puerto Rico and Key West, Florida, during 2010 Epidemics. Am J Trop Med Hyg 87: 548-553.
42. Santiago GA, McElroy-Horne K, Lennon NJ, Santiago LM, Birren BW, et al. (2012) Reemergence and decline of dengue virus serotype 3 in Puerto Rico. J Infect Dis 206: 893-901.
43. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, et al. (2010) Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4: e617.
44. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, et al. (2003) Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68: 191-202.
45. Buchy P, Vo VL, Bui KT, Trinh TX, Glaziou P, et al. (2005) Secondary dengue virus type 4 infections in Vietnam. Southeast Asian J Trop Med Public Health 36: 178-185.
46. Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, et al. (2000) Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am J Epidemiol 152: 793-799 discussion 804.
47. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.
48. Anantapreecha S, Chanama S, A An, Naemkhunthot S, Sa-Ngasang A, et al. (2005) Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002. Epidemiol Infect 133: 503-507.
49. Thu HM, Lowry K, Myint TT, Shwe TN, Han AM, et al. (2004) Myanmar dengue outbreak associated with displacement of serotypes 2, 3, and 4 by dengue 1. Emerg Infect Dis 10: 593-597.
50. Balmaseda A, Hammond SN, Perez L, Tellez Y, Saborio SI, et al. (2006) Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 74: 449-456.
51. Nishiura H, Halstead SB, (2007) Natural history of dengue virus (DENV)-1 and DENV-4 infections: reanalysis of classic studies. J Infect Dis 195: 1007-1013.
52. Fagbami AH, Mataika JU, Shrestha M, Gubler DJ, (1995) Dengue type 1 epidemic with haemorrhagic manifestations in Fiji, 1989-90. Bull World Health Organ 73: 291-297.
53. Rico-Hesse R, (2007) Dengue virus evolution and virulence models. Clin Infect Dis 44: 1462-1466.
54. Ohainle M, Balmaseda A, Macalalad AR, Tellez Y, Zody MC, et al. (2011) Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med 3: 114ra128.
55. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, et al. (2004) Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189: 990-1000.
56. Kyle JL, Harris E, (2008) Global spread and persistence of dengue. Annu Rev Microbiol 62: 71-92.
57. Gubler DJaK, G. (1997) Dengue and Dengue Hemorrhagic Fever: CABI. 478 p.
58. Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, et al. (1989) Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70 (Pt 1) (): 37-43.